Rocket Stocks Hot Sheet

WARNING: THE FOLLOWING CONTENT ABOUT ROCKET STOCKS IS FROM AN ONGOING STUDY BEING CONDUCTED BY THE PLUTU$ ANALYTICAL TEAM. THE DATA PRESENTED HERE FROM THIS STUDY IS MEANT TO ILLUSTRATE THE OBSERVATIONS THAT HAVE BEEN MADE DURING THIS STUDY OR OPINIONS BASED ON THESE OBSERVATIONS. IT IS IN NO WAY A RECOMMENDATION OR ENDORSEMENT FOR ANY SPECIFIC TRADING OR INVESTMENT STRATEGY.

The following is a list of sectors, keywords, actions, and other things which the PLUTU$ Analytical Team has found to be currently prevalent in rocket stocks. This list is sometimes updated to correspond with market fluctuations and trends and is based on the observations and analysis of rocket stocks by the PLUTU$ Analytical Team. This is not an exhaustive list and this hot sheet is part of what the PLUTU$ Analytical Team utilizes when analyzing rocket stocks. This hot sheet is not meant or recommended for use by any trader or investor for any type of trading or investment purposes. It is for analytical purposes only and given as an example to illustrate a point. The data used to create this hot sheet can be accessed in the Rocket Stocks Spreadsheet News Catalyst column which contains hyperlinks to past PRs and SEC filings that resulted in a stock rocketing.

  • 510K Submissions or Approvals
  • ADHD
  • Biotechnology
  • Blockchain or Cryptocurrency
  • COVID19 or Coronavirus
  • CRISPR
  • Cancer
  • Cannabidiol (CBD) medical treatments
  • Cannabis
  • Clinical Trials with positive topline results.
  • Clinical Trials with a Proof of Concept.
  • Company eliminating debt or increasing shareholder value, compared with market cap.
  • Company starting a new venture in a hot sector.
  • Company reporting earnings with a massive increase in sales and revenue.
  • Diabetes
  • Electric Vehicles
  • Endorsement or partnership with a major celebrity.
  • FDA Meetings, depends on type, but also if it is requested and the outcome.
  • Gene Therapies
  • Government approval FDA, SEC, FCC, or other regulatory agency of a new technology or drug or the lifting of a ban on a new technology or drug.
  • High Cholesterol
  • Migraine Headaches
  • Pain Relief
  • Parkinson's Disease
  • Patent approval of an inovative technology
  • Small company getting a contract with a major company especially a Fortune 500 company.
  • Small company getting major contract and it exceeds their market cap.
  • Small company getting big distribution deal especially with Amazon.
  • Stem Cells
  • T-Cell therapies
  • Telemedicine
  • University licensing agreement to a pharmaceutical company for a drug they have developed.
  • NOTE: Also see the Sectors of Interest section in the Financepedia widget on the PLUTU$ homepage While the Sectors of Interest is focused more on long-term investing it does contain some of the items listed on this hot sheet.

Rocket Stocks 2020 Tag Cloud

Rocket Stocks 2020 Tag Cloud

NOTE: The rocket stocks 2020 tag cloud is based on the words contained in all 299 official news catalyst PRs and SEC filings from the year 2020. The entire list of words and weight used to generate the rocket stock 2020 tag cloud can be viewed in the Rocket Stocks 2020 Tag Cloud CSV file. In order to create a more relevant and visually balanced tag cloud, many common or irrelevant words have been removed.

LEGAL DISCLAIMER

Any content or services provided by PLUTU$ does not constitute a solicitation nor should it be construed as investment or trading advice, or an offer, recommendation, or endorsement to buy or sell any securities or related financial instruments, and PLUTU$ makes no representation and has no opinion regarding the advisability or suitability of any investment or trading of any security or other financial instruments. Any securities or related financial instruments mentioned in the content and services provided by PLUTU$ are done so for informational or reference purposes only or given as an example to illustrate an opinion or observation. Some content and services provided by PLUTU$ may be educational or observational in nature and is not designed to recommend or endorse any specific financial, trading, or investment product, service, or strategy.

This excerpt is taken from the PLUTU$ Disclaimer and is part of the PLUTU$ Terms Of Service which all PLUTU$ users are legally bound by.

PLUTU$ - 'Financial insight without all the noise.'